Daiying Zuo

3.0k citations

104 papers · 2.5k indexed · h-index 28

Molecular Biology top 10%
Organic Chemistry top 5%
Oncology top 10%
Materials Chemistry
Cellular and Molecular Neuroscience top 10%

Co-authors: Yingliang Wu Zengqiang Li Weige Zhang Qi Guan Kai Bao Xuewei Jiang Xuejiao Zhou Jingwen Xu
Topics: Synthesis and biological activity (30 papers)Cancer therapeutics and mechanisms (17 papers)Lung Cancer Treatments and Mutations (17 papers)
Cited by: Biological Psychiatry Toxicology Organic Chemistry
Journals: Journal of Biological Chemistry PLoS ONE Scientific Reports
Partner nations: China United States Japan

In The Last Decade

Daiying Zuo

101 papers receiving 2.4k citations

Peers

Countries citing papers authored by Daiying Zuo

Since Specialization

Citations

This map shows the geographic impact of Daiying Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daiying Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daiying Zuo more than expected).

Fields of papers citing papers by Daiying Zuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daiying Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daiying Zuo. The network helps show where Daiying Zuo may publish in the future.

Co-authorship network of co-authors of Daiying Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Daiying Zuo. A scholar is included among the top collaborators of Daiying Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daiying Zuo. Daiying Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Repositioning miconazole: a novel drug for inducing cell death and differentiation in myeloid leukemia 2025 ·Biochemical Pharmacology ·Fang Li,Lin Zuo,Fei Xing,Yajie Wang,Ruijuan Chen,Fengjiao Zhang,Daiying Zuo	0
2	EML4‐ALK G1202R and EML4‐ALK L1196M mutations induce crizotinib resistance in non‐small cell lung cancer cells through activating epithelial–mesenchymal transition mediated by MDM2/MEK/ERK signal axis 2024 ·Cell Biology International ·Yuying Yang,Huan Yang,(unknown),Qian Yang,(unknown),(unknown),Xiaobo Xu,Zengqiang Li,Daiying Zuo	3
3	Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT 2023 ·Biochemical Pharmacology ·(unknown),Jingang Liu,Qian Yang,Yu Gao,(unknown),(unknown),Yang Li,Zi Liu,Zengqiang Li,Yingliang Wu,Daiying Zuo	9
4	CD74–ROS1 L2026M mutant enhances autophagy through the MEK / ERK pathway to promote invasion, metastasis and crizotinib resistance in non‐small cell lung cancer cells 2023 ·FEBS Journal ·Xiaobo Xu,Li Ye,Rui Xu,Yuting Meng,Zengqiang Li,Daiying Zuo,Yingliang Wu	3
5	A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non–small cell lung cancers 2022 ·Journal of Biological Chemistry ·Zi Liu,(unknown),Tianhao Zhou,(unknown),Yuying Yang,(unknown),(unknown),Zengqiang Li,Yingliang Wu,Qi Guan,Weige Zhang,Daiying Zuo	11
6	XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer 2022 ·Biomedicine & Pharmacotherapy ·Shan Xu,Xin Sun,(unknown),Yang Yang,Qiuyan Guo,Sheng Tang,(unknown),Yuzhen Li,(unknown),Wenhui Gan,(unknown),Xuan Zhang,Yijun Liu,(unknown),Jie He,(unknown),Daiying Zuo,Wufu Zhu,Yingliang Wu	17
7	Design, synthesis and biological evaluation of 3,4-diaryl-1,2,5-oxadiazole-2/5-oxides as highly potent inhibitors of tubulin polymerization 2019 ·European Journal of Medicinal Chemistry ·(unknown),Yinglin Zhao,Lei Yang,(unknown),(unknown),(unknown),Zhan Wang,Qi Guan,Kai Bao,Daiying Zuo,Yingliang Wu,Weige Zhang	6
8	CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib 2018 ·Cancer Letters ·Wenfeng Gou,Xuejiao Zhou,Zi Liu,Lijing Wang,(unknown),Xiaobo Xu,Zengqiang Li,Xin Zhai,Daiying Zuo,Yingliang Wu	46
9	Dual potent ALK and ROS1 inhibitors combating drug-resistant mutants: Synthesis and biological evaluation of aminopyridine-containing diarylaminopyrimidine derivatives 2018 ·European Journal of Medicinal Chemistry ·Ming Guo,Daiying Zuo,Jun‐Long Zhang,(unknown),Wenfeng Gou,(unknown),Nan Jiang,Dajun Zhang,Xin Zhai	24
10	Alcohol aggravates ketamine-induced behavioral, morphological and neurochemical alterations in adolescent rats: The involvement of CREB-related pathways 2018 ·Behavioural Brain Research ·Daiying Zuo,(unknown),(unknown),(unknown),Xuejiao Zhou,Yang Liu,Zengqiang Li,Yingliang Wu	8
11	5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-((4-methylpiperazin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)phenyl)pyrimidine-2,4-diamine (WY-135), a novel ALK inhibitor, induces cell cycle arrest and apoptosis through inhibiting ALK and its downstream pathways in Karpas299 and H2228 cells 2018 ·Chemico-Biological Interactions ·Mengting Han,(unknown),Lijing Wang,Yu Wang,Xin Zhai,Yao Li,(unknown),Zengqiang Li,Daiying Zuo,Yingliang Wu	9
12	Synthesis and bioevaluation of N,4-diaryl-1,3-thiazole-2-amines as tubulin inhibitors with potent antiproliferative activity 2017 ·PLoS ONE ·Maolin Sun,(unknown),Jingwen Xu,Yue Wu,Yueting Wang,Daiying Zuo,Qi Guan,Kai Bao,Jian Wang,Yingliang Wu,Weige Zhang	28
13	Synthesis, biological evaluation and molecular modeling of imidazo[1,2-a]pyridine derivatives as potent antitubulin agents 2017 ·Bioorganic & Medicinal Chemistry ·(unknown),Daiying Zuo,(unknown),Ming Guo,(unknown),Wenyu Zhang,Jianwen Zhao,Jiwei Shen,Ping Gong,Dajun Zhang,Xin Zhai	16
14	Discovery and Optimization of Novel 5-Indolyl-7-arylimidazo[1,2-a]pyridine-8-carbonitrile Derivatives as Potent Antitubulin Agents Targeting Colchicine-binding Site 2017 ·Scientific Reports ·Xin Zhai,Xiaoqiang Wang,Jiao Wang,Jin Liu,Daiying Zuo,Nan Jiang,(unknown),Xiuxiu Yang,(unknown),Ping Gong	16
15	Design, synthesis and biological evaluation of novel 4-arylaminopyrimidine derivatives possessing a hydrazone moiety as dual inhibitors of L1196M ALK and ROS1 2016 ·European Journal of Medicinal Chemistry ·Yu Wang,Guogang Zhang,Gang Hu,(unknown),(unknown),Daiying Zuo,Mengting Han,(unknown),Ping Gong	28
16	Ultrasound-promoted two-step synthesis of 3-arylselenylindoles and 3-arylthioindoles as novel combretastatin A-4 analogues 2016 ·Scientific Reports ·Zhiyong Wen,Xiaona Li,Daiying Zuo,(unknown),Yang‐Chang Wu,Mingyang Jiang,(unknown),Kai Bao,Yingliang Wu,Weige Zhang	40
17	Amphipathic silica nanoparticles induce cytotoxicity through oxidative stress mediated and p53 dependent apoptosis pathway in human liver cell line HL-7702 and rat liver cell line BRL-3A 2016 ·Colloids and Surfaces B Biointerfaces ·Daiying Zuo,(unknown),Yuanyuan Jia,(unknown),Qiong He,Juan Yuan,Wei Dai,Zengqiang Li,Liguo Xing,Yingliang Wu	37
18	DAT-230, a novel microtubule inhibitor, exhibits potent anti-tumor activity by inducing G2/M phase arrest, apoptosis in vitro and perfusion decrease in vivo to HT-1080 2012 ·Cancer Chemotherapy and Pharmacology ·(unknown),Daiying Zuo,(unknown),Huan Qi,Haifeng Wang,Weige Zhang,Yingliang Wu	15
19	Effects of N-Acetylaspartylglutamate (NAAG) Peptidase Inhibition on Release of Glutamate and Dopamine in Prefrontal Cortex and Nucleus Accumbens in Phencyclidine Model of Schizophrenia 2012 ·Journal of Biological Chemistry ·Daiying Zuo,Tomasz Bzdega,Rafal T. Olszewski,John R. Moffett,Joseph H. Neale	44
20	Effects of amiloride on behavior and extracellular glutamate level of frontal cortex in acute epileptic mice induced by penicillin 2006 ·Zhongguo yaolixue tongbao ·Daiying Zuo	2

About Daiying Zuo

Daiying Zuo is a scholar working on Biological Psychiatry, Developmental Neuroscience and Oncology, having authored 104 papers that have together received 2.5k indexed citations. Recurring topics across this work include Synthesis and biological activity (30 papers), Cancer therapeutics and mechanisms (17 papers) and Lung Cancer Treatments and Mutations (17 papers). The work is most often cited by research in Biological Psychiatry (121 citations), Toxicology (131 citations) and Organic Chemistry (684 citations). Daiying Zuo has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yingliang Wu, Zengqiang Li, Weige Zhang, Qi Guan, Kai Bao, Xuewei Jiang, Xuejiao Zhou, Jingwen Xu, Huan Qi and Zi Liu. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact